ARCHIVES

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

British Award 100,000 Pounds A Year To UICC

January 11, 1980

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

In Brief: NASA Procurement Specialist Names NEW NCI Contracts Chief; NIH Delays CREG Approval

January 3, 1975

ASCO And ESMO Publish Training Recommendations

November 26, 2004

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002